NCT03518099 Searching Biomarkers of Acute Intestinal Ischemic Injuries
| NCT ID | NCT03518099 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Acute Mesenteric Ischemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 556 participants |
| Start Date | 2018-11-16 |
| Primary Completion | 2027-12-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The aim of the SURVIBIO study is to characterize accurate biomarkers for acute mesenteric ischemia, in particular at early stages. In the study, the development of biomarkers will be based on the analysis of human biological samples from patients and controls that will be conserved in a biological library. Samples will be analysed in the Laboratory for Vascular Translational Sciences (LVTS, Inserm U1148), in the Department of Biochemistry (Pr Puy, Dr Peoc'h), in Paris V university , in Imperial College of London (Pr Dumas), in Jacques Monod Institute and in Maastricht University Medical Center . The candidate markers will be determined according to an a priori method (form markers already described in the literature) and with no a priori strategy using -omics methods.
Eligibility Criteria
Inclusion Criteria: * age\> 18 years * Acute abdominal pain requiring an injected abdominal injected CT scan, at best at non-injected / early arterial / portal time * Admitted or attended in Beaujon and / or Bichat hospitals * Patient covered by a social security scheme * Written consent Exclusion Criteria: • lack of abdominal CT scan